Cargando…
Insulin-like growth factor-1 improves diabetic cardiomyopathy through antioxidative and anti-inflammatory processes along with modulation of Akt/GSK-3β signaling in rats
Diabetic cardiomyopathy (DCM), a serious complication of diabetes mellitus, is associated with changes in myocardial structure and function. This study sought to explore the ability of insulin-like growth factor-1 (IGF-1) to modulate DCM and its related mechanisms. Twenty-four male Wistar rats were...
Autores principales: | Wang, Cheng Yu, Li, Xiang Dan, Hao, Zhi Hong, Xu, Dongyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106395/ https://www.ncbi.nlm.nih.gov/pubmed/27847438 http://dx.doi.org/10.4196/kjpp.2016.20.6.613 |
Ejemplares similares
-
Urocortin ameliorates diabetic cardiomyopathy in rats via the Akt/GSK-3β signaling pathway
por: LIU, XINYU, et al.
Publicado: (2015) -
AKT/GSK3β Signaling in Glioblastoma
por: Majewska, Ewelina, et al.
Publicado: (2016) -
Emodin Protects against Diabetic Cardiomyopathy by Regulating the AKT/GSK-3β Signaling Pathway in the Rat Model
por: Wu, Zhiqin, et al.
Publicado: (2014) -
Effects of cGMP/Akt/GSK-3β signaling pathway on atrial natriuretic peptide secretion in rabbits with rapid atrial pacing
por: Cao, Shuxia, et al.
Publicado: (2022) -
Protective effect of salidroside on streptozotocin-induced diabetic nephropathy by inhibiting oxidative stress and inflammation in rats via the Akt/GSK-3β signalling pathway
por: Pei, Delong, et al.
Publicado: (2022)